Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04151199 · ClinicalTrials.gov registry record · NA
Molecular Transducers of Physical Activity Consortium (MoTrPAC) - Pediatric Protocol
A NA study, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- NA
- Development phase
- 320
- Enrollment target
NCT04151199 is a NA study that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 320 participants.
The verdict
NCT04151199, a NA study, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 320 participants
- Enrollment target
Study Summary
The goal of the Molecular Transducers of Physical Activity Consortium (MoTrPAC) is to assess molecular changes that occur in response to physical activity (PA). To achieve this aim, studies will be conducted in adults and separately in children and adolescents. The UC Irvine MoTrPAC Pediatric Clinical Center oversees two interrelated study phases in children and adolescents: 1. A cross-sectional phase in which molecular transducers (obtained from blood sampling) are measured in response to an acute exercise challenge (n = 320); 2. An intervention phase is conducted as a mechanistic randomized controlled trial (RCT). Participants are recruited from the cross-sectional study phase and randomized to endurance exercise (EE) training (n = 120) or no exercise Control (n = 50) for a period of approximately 12 weeks.
Interventions
- OTHER EE Training
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 320 participants |
| Start Date | 2019-11-22 |
| Est. Completion | 2025-05-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04151199
The ClinicalTrials.gov registry entry for NCT04151199 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 320 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which EE Training is the first listed.
NCT04151199 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04151199 about?
NCT04151199 is a clinical study titled "Molecular Transducers of Physical Activity Consortium (MoTrPAC) - Pediatric Protocol". The goal of the Molecular Transducers of Physical Activity Consortium (MoTrPAC) is to assess molecular changes that occur in response to physical activity (PA). To achieve this aim, studies will be conducted in adults and separately in children and adolescents. The UC Irvine MoTrPAC Pediatric Clinic...
What is the current status of trial NCT04151199?
This trial is currently completed. It is a NA study. The enrollment target is 320 participants. The study started on 2019-11-22. Estimated completion is 2025-05-31.
What interventions are being tested in trial NCT04151199?
The interventions under investigation include: EE Training (OTHER).
Who is sponsoring clinical trial NCT04151199?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.